Lenscrafters #01156 | |
210 Andover St, S109b, Peabody, Massachusetts 01960 | |
(978) 531-9440 |
Name | Lenscrafters #01156 |
---|---|
Organization Name | Luxottica Of America Inc |
Location | 210 Andover St, S109b, Peabody, Massachusetts 01960 |
Type | Eyewear Supplier (Equipment, not the service) |
Phone | (978) 531-9440 |
Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Boehringer Ingelheim and Eli Lilly and Company today announced results of a 102 week Phase III study for linagliptin, which show meaningful and durable reductions in blood glucose for adults with type 2 diabetes.
A team of researchers from Keele University has found that it is uncommon for older adults to consult their GP during times of distress due to a lack of acceptable treatments.
The Hyde Park Neighborhood Club provides an example of how engaged individuals can sustain communities through long lasting stability.
NeuIsys Imaging System Solutions, LLC, a leader in providing state-of-the-art CT and MR imaging systems to physician practices, announced today that three gastroenterology (GI) practices have entered into agreements with NeuIsys to plan, install, and service the recently FDA approved NeuViz 16 Multi-Slice Computed Tomography (CT) System.
Advanced Cell Technology, Inc. announced today that it is positioned to obtain significant patents relating to cellular reprogramming and the generation of induced pluripotent stem (iPS) cells. iPS cells are similar to embryonic stem (ES) cells, except they are generated from adult cells such as skin using certain reprogramming factors, without the controversial use of embryos. Although human iPS cells were first produced in 2007, ACT has been working on inducing pluripotency, with positive results, for more than a decade. The Company's efforts go back to the 1990s, providing (through existing patent filings and continuations) some of the earliest priority dates in the field.
› Verified 5 days ago
NPI Number | 1730241951 |
Organization Name | LUXOTTICA OF AMERICA INC. |
Doing Business As | LENSCRAFTERS #1156 |
Type | Eyewear Supplier (Equipment, not the service) |
Address | 210 Andover St # S109b, Peabody, MA 01960 |
Phone Number | 978-531-9440 |
News Archive
Boehringer Ingelheim and Eli Lilly and Company today announced results of a 102 week Phase III study for linagliptin, which show meaningful and durable reductions in blood glucose for adults with type 2 diabetes.
A team of researchers from Keele University has found that it is uncommon for older adults to consult their GP during times of distress due to a lack of acceptable treatments.
The Hyde Park Neighborhood Club provides an example of how engaged individuals can sustain communities through long lasting stability.
NeuIsys Imaging System Solutions, LLC, a leader in providing state-of-the-art CT and MR imaging systems to physician practices, announced today that three gastroenterology (GI) practices have entered into agreements with NeuIsys to plan, install, and service the recently FDA approved NeuViz 16 Multi-Slice Computed Tomography (CT) System.
Advanced Cell Technology, Inc. announced today that it is positioned to obtain significant patents relating to cellular reprogramming and the generation of induced pluripotent stem (iPS) cells. iPS cells are similar to embryonic stem (ES) cells, except they are generated from adult cells such as skin using certain reprogramming factors, without the controversial use of embryos. Although human iPS cells were first produced in 2007, ACT has been working on inducing pluripotency, with positive results, for more than a decade. The Company's efforts go back to the 1990s, providing (through existing patent filings and continuations) some of the earliest priority dates in the field.
› Verified 5 days ago
NPI Number | 1962957019 |
Organization Name | LUXOTTICA OF AMERICA INC. |
Doing Business As | LENSCRAFTERS #3224 |
Type | Eyewear Supplier (Equipment, not the service) |
Address | 210 Andover St, Peabody, MA 01960 |
Phone Number | 978-532-0216 |
News Archive
Boehringer Ingelheim and Eli Lilly and Company today announced results of a 102 week Phase III study for linagliptin, which show meaningful and durable reductions in blood glucose for adults with type 2 diabetes.
A team of researchers from Keele University has found that it is uncommon for older adults to consult their GP during times of distress due to a lack of acceptable treatments.
The Hyde Park Neighborhood Club provides an example of how engaged individuals can sustain communities through long lasting stability.
NeuIsys Imaging System Solutions, LLC, a leader in providing state-of-the-art CT and MR imaging systems to physician practices, announced today that three gastroenterology (GI) practices have entered into agreements with NeuIsys to plan, install, and service the recently FDA approved NeuViz 16 Multi-Slice Computed Tomography (CT) System.
Advanced Cell Technology, Inc. announced today that it is positioned to obtain significant patents relating to cellular reprogramming and the generation of induced pluripotent stem (iPS) cells. iPS cells are similar to embryonic stem (ES) cells, except they are generated from adult cells such as skin using certain reprogramming factors, without the controversial use of embryos. Although human iPS cells were first produced in 2007, ACT has been working on inducing pluripotency, with positive results, for more than a decade. The Company's efforts go back to the 1990s, providing (through existing patent filings and continuations) some of the earliest priority dates in the field.
› Verified 5 days ago
News Archive
Boehringer Ingelheim and Eli Lilly and Company today announced results of a 102 week Phase III study for linagliptin, which show meaningful and durable reductions in blood glucose for adults with type 2 diabetes.
A team of researchers from Keele University has found that it is uncommon for older adults to consult their GP during times of distress due to a lack of acceptable treatments.
The Hyde Park Neighborhood Club provides an example of how engaged individuals can sustain communities through long lasting stability.
NeuIsys Imaging System Solutions, LLC, a leader in providing state-of-the-art CT and MR imaging systems to physician practices, announced today that three gastroenterology (GI) practices have entered into agreements with NeuIsys to plan, install, and service the recently FDA approved NeuViz 16 Multi-Slice Computed Tomography (CT) System.
Advanced Cell Technology, Inc. announced today that it is positioned to obtain significant patents relating to cellular reprogramming and the generation of induced pluripotent stem (iPS) cells. iPS cells are similar to embryonic stem (ES) cells, except they are generated from adult cells such as skin using certain reprogramming factors, without the controversial use of embryos. Although human iPS cells were first produced in 2007, ACT has been working on inducing pluripotency, with positive results, for more than a decade. The Company's efforts go back to the 1990s, providing (through existing patent filings and continuations) some of the earliest priority dates in the field.
› Verified 5 days ago
Cvs Pharmacy #48266 Type: Long Term Care Pharmacy Location: 100 Brooksby Village Dr, Peabody, Massachusetts 01960 Phone: (978) 326-2350 | |
Cvs Pharmacy # 00318 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 637 Lowell Street, Peabody, Massachusetts 01960 Phone: (978) 535-5465 | |
Cvs Pharmacy # 04073 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 174 Main St, Peabody, Massachusetts 01960 Phone: (978) 977-4844 | |
Cvs Pharmacy # 02533 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 79 Lynnfield Street, Peabody, Massachusetts 01960 Phone: (978) 531-6953 | |
Cvs Pharmacy # 01014 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 535 Lowell Street, Peabody, Massachusetts 01960 Phone: (978) 535-2062 |